Kathryn Haviland
Kathryn Haviland, serves as President, Chief Executive Officer & Director of Blueprint Medicines Corporation since 2022 and has been its Chief Operating Officer since 2019 until 2022. Ms. Haviland built
Kathryn Haviland, serves as President, Chief Executive Officer & Director of Blueprint Medicines Corporation since 2022 and has been its Chief Operating Officer since 2019 until 2022. Ms. Haviland built